Cargando…

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya

BACKGROUND: Additional progress towards HIV epidemic control requires understanding who remains at risk of HIV infection in the context of high uptake of universal testing and treatment (UTT). We sought to characterize seroconverters and risk factors in the SEARCH UTT trial (NCT01864603), which achi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyabuti, Marilyn N., Petersen, Maya L., Bukusi, Elizabeth A., Kamya, Moses R., Mwangwa, Florence, Kabami, Jane, Sang, Norton, Charlebois, Edwin D., Balzer, Laura B., Schwab, Joshua D., Camlin, Carol S., Black, Douglas, Clark, Tamara D., Chamie, Gabriel, Havlir, Diane V., Ayieko, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864429/
https://www.ncbi.nlm.nih.gov/pubmed/33544717
http://dx.doi.org/10.1371/journal.pone.0243167
_version_ 1783647661312704512
author Nyabuti, Marilyn N.
Petersen, Maya L.
Bukusi, Elizabeth A.
Kamya, Moses R.
Mwangwa, Florence
Kabami, Jane
Sang, Norton
Charlebois, Edwin D.
Balzer, Laura B.
Schwab, Joshua D.
Camlin, Carol S.
Black, Douglas
Clark, Tamara D.
Chamie, Gabriel
Havlir, Diane V.
Ayieko, James
author_facet Nyabuti, Marilyn N.
Petersen, Maya L.
Bukusi, Elizabeth A.
Kamya, Moses R.
Mwangwa, Florence
Kabami, Jane
Sang, Norton
Charlebois, Edwin D.
Balzer, Laura B.
Schwab, Joshua D.
Camlin, Carol S.
Black, Douglas
Clark, Tamara D.
Chamie, Gabriel
Havlir, Diane V.
Ayieko, James
author_sort Nyabuti, Marilyn N.
collection PubMed
description BACKGROUND: Additional progress towards HIV epidemic control requires understanding who remains at risk of HIV infection in the context of high uptake of universal testing and treatment (UTT). We sought to characterize seroconverters and risk factors in the SEARCH UTT trial (NCT01864603), which achieved high uptake of universal HIV testing and ART coverage in 32 communities of adults (≥15 years) in rural Uganda and Kenya. METHODS: In a pooled cohort of 117,114 individuals with baseline HIV negative test results, we described those who seroconverted within 3 years, calculated gender-specific HIV incidence rates, evaluated adjusted risk ratios (aRR) for seroconversion using multivariable targeted maximum likelihood estimation, and assessed potential infection sources based on self-report. RESULTS: Of 704 seroconverters, 63% were women. Young (15–24 years) men comprised a larger proportion of seroconverters in Western Uganda (18%) than Eastern Uganda (6%) or Kenya (10%). After adjustment for other risk factors, men who were mobile [≥1 month of prior year living outside community] (aRR:1.68; 95%CI:1.09,2.60) or who HIV tested at home vs. health fair (aRR:2.44; 95%CI:1.89,3.23) were more likely to seroconvert. Women who were aged ≤24 years (aRR:1.91; 95%CI:1.27,2.90), mobile (aRR:1.49; 95%CI:1.04,2.11), or reported a prior HIV test (aRR:1.34; 95%CI:1.06,1.70), or alcohol use (aRR:2.07; 95%CI:1.34,3.22) were more likely to seroconvert. Among survey responders (N = 607, 86%), suspected infection source was more likely for women than men to be ≥10 years older (28% versus 8%) or a spouse (51% vs. 31%) and less likely to be transactional sex (10% versus 16%). CONCLUSION: In the context of universal testing and treatment, additional strategies tailored to regional variability are needed to address HIV infection risks of young women, alcohol users, mobile populations, and those engaged in transactional sex to further reduce HIV incidence rates.
format Online
Article
Text
id pubmed-7864429
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78644292021-02-12 Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya Nyabuti, Marilyn N. Petersen, Maya L. Bukusi, Elizabeth A. Kamya, Moses R. Mwangwa, Florence Kabami, Jane Sang, Norton Charlebois, Edwin D. Balzer, Laura B. Schwab, Joshua D. Camlin, Carol S. Black, Douglas Clark, Tamara D. Chamie, Gabriel Havlir, Diane V. Ayieko, James PLoS One Research Article BACKGROUND: Additional progress towards HIV epidemic control requires understanding who remains at risk of HIV infection in the context of high uptake of universal testing and treatment (UTT). We sought to characterize seroconverters and risk factors in the SEARCH UTT trial (NCT01864603), which achieved high uptake of universal HIV testing and ART coverage in 32 communities of adults (≥15 years) in rural Uganda and Kenya. METHODS: In a pooled cohort of 117,114 individuals with baseline HIV negative test results, we described those who seroconverted within 3 years, calculated gender-specific HIV incidence rates, evaluated adjusted risk ratios (aRR) for seroconversion using multivariable targeted maximum likelihood estimation, and assessed potential infection sources based on self-report. RESULTS: Of 704 seroconverters, 63% were women. Young (15–24 years) men comprised a larger proportion of seroconverters in Western Uganda (18%) than Eastern Uganda (6%) or Kenya (10%). After adjustment for other risk factors, men who were mobile [≥1 month of prior year living outside community] (aRR:1.68; 95%CI:1.09,2.60) or who HIV tested at home vs. health fair (aRR:2.44; 95%CI:1.89,3.23) were more likely to seroconvert. Women who were aged ≤24 years (aRR:1.91; 95%CI:1.27,2.90), mobile (aRR:1.49; 95%CI:1.04,2.11), or reported a prior HIV test (aRR:1.34; 95%CI:1.06,1.70), or alcohol use (aRR:2.07; 95%CI:1.34,3.22) were more likely to seroconvert. Among survey responders (N = 607, 86%), suspected infection source was more likely for women than men to be ≥10 years older (28% versus 8%) or a spouse (51% vs. 31%) and less likely to be transactional sex (10% versus 16%). CONCLUSION: In the context of universal testing and treatment, additional strategies tailored to regional variability are needed to address HIV infection risks of young women, alcohol users, mobile populations, and those engaged in transactional sex to further reduce HIV incidence rates. Public Library of Science 2021-02-05 /pmc/articles/PMC7864429/ /pubmed/33544717 http://dx.doi.org/10.1371/journal.pone.0243167 Text en © 2021 Nyabuti et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nyabuti, Marilyn N.
Petersen, Maya L.
Bukusi, Elizabeth A.
Kamya, Moses R.
Mwangwa, Florence
Kabami, Jane
Sang, Norton
Charlebois, Edwin D.
Balzer, Laura B.
Schwab, Joshua D.
Camlin, Carol S.
Black, Douglas
Clark, Tamara D.
Chamie, Gabriel
Havlir, Diane V.
Ayieko, James
Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title_full Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title_fullStr Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title_full_unstemmed Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title_short Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
title_sort characteristics of hiv seroconverters in the setting of universal test and treat: results from the search trial in rural uganda and kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864429/
https://www.ncbi.nlm.nih.gov/pubmed/33544717
http://dx.doi.org/10.1371/journal.pone.0243167
work_keys_str_mv AT nyabutimarilynn characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT petersenmayal characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT bukusielizabetha characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT kamyamosesr characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT mwangwaflorence characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT kabamijane characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT sangnorton characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT charleboisedwind characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT balzerlaurab characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT schwabjoshuad characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT camlincarols characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT blackdouglas characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT clarktamarad characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT chamiegabriel characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT havlirdianev characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya
AT ayiekojames characteristicsofhivseroconvertersinthesettingofuniversaltestandtreatresultsfromthesearchtrialinruralugandaandkenya